Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis

Gene

Volumn 546, Issue 1, 2014, Pages 117-123

  Cai, Guoqing ^a   Ma, Xiangdong ^a   Zou, Wei ^a   Huang, Yanhong ^a   Zhang, Junru ^a   Wang, Detang ^a   Chen, Biliang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; ICAM 1; Polymorphism; Survival

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIRST DEGREE RELATIVE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENARCHE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; UPREGULATION;

EPITHELIAL OVARIAN CANCER; ICAM-1; POLYMORPHISM; SURVIVAL;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MENARCHE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84901826422     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.049     Document Type: Article

References (45)

1. Alexiou D., et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am. J. Gastroenterol. 2003, 98:478-485.
2. Arnold J.M., Cummings M., Purdie D., Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br. J. Cancer 2001, 85:1351-1358.
3. Arocho A., Chen B., Ladanyi M., Pan Q. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn. Mol. Pathol. 2006, 15:56-61.
4. Barrett J., Fry B., Maller J., Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Beral V., Gaitskell K., Hermon C., Moser K., Reeves G., Peto R. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol. 2012, 13:946-956.
6. Beral V., Hermon C., Peto R., Reeves G., Brinton L. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 2012, 9:e1001200.
7. Bonello N., Jasper M.J., Norman R.J. Periovulatory expression of intercellular adhesion molecule-1 in the rat ovary. Biol. Reprod. 2004, 71:1384-1390.
8. Brooks K.J., Coleman E.J., Vitetta E.S. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int. J. Cancer 2008, 123:2438-2445.
9. Buitrago D., et al. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Ann. Surg. Oncol. 2011, 19:973-980.
10. Callet N., Delaunay J., Pichon M. Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers. Eur. J. Gynaecol. Oncol. 2000, 21:135-140.
11. Chang Y.J., Holtzman M.J., Chen C.C. Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway. J. Biol. Chem. 2002, 277:7118-7126.
12. Chen H., Hernandez W., Shriver M.D., Ahaghotu C.A., Kittles R.A. ICAM gene cluster SNPs and prostate cancer risk in African Americans. Hum. Genet. 2006, 120:69-76.
13. Fasching P.A., et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol. Oncol. 2009, 3:171-181.
14. Fathalla M.F. Incessant ovulation-a factor in ovarian neoplasia?. Lancet 1971, 2:163.
15. Fujihara T., et al. Decrease in ICAM-1 expression on gastric cancer cells is correlated with lymph node metastasis. Gastric Cancer 1999, 2:221-225.
16. Gong T.T., Wu Q.J., Vogtmann E., Lin B., Wang Y.L. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int. J. Cancer 2013, 132:2894-2900.
17. Guney N., et al. Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer. Med. Oncol. 2008, 25:194-200.
18. Holder A.L., et al. Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum. Immunol. 2008, 69:71-78.
19. Hubbard A.K., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic. Biol. Med. 2000, 28:1379-1386.
20. Joling P., et al. Domain 5 of the intercellular adhesion molecule-1 (ICAM-1) is involved in adhesion of B-cells and follicular dendritic cells. Adv. Exp. Med. Biol. 1994, 355:131-135.
21. Kammerer S., et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 2004, 64:8906-8910.
22. Kevil C.G., et al. Intercellular adhesion molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway. J. Biol. Chem. 2004, 279:19230-19238.
23. Kim I., Moon S.O., Hoon Kim S., Jin Kim H., Soon Koh Y., Young Koh G. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J. Biol. Chem. 2001, 276:7614-7620.
24. Li X., Klintman D., Weitz-Schmidt G., Schramm R., Thorlacius H. Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. Br. J. Pharmacol. 2004, 141:709-716.
25. Lin Y.C., Shun C.T., Wu M.S., Chen C.C. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-κB. Clin. Cancer Res. 2006, 12:7165-7173.
26. Maeda K., et al. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol. Rep. 2002, 9:511-514.
27. Makar A.P., Baekelandt M., Trope C.G., Kristensen G.B. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol. Oncol. 1995, 56:175-180.
28. Maruo Y., et al. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int. J. Cancer 2002, 100:486-490.
29. Miele M.E., Bennett C.F., Miller B.E., Welch D.R. Enhanced metastatic ability of TNF-[alpha]-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp. Cell. Res. 1994, 214:231-241.
30. Mulder W., et al. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. Clin. Cancer Res. 1997, 3:1923-1930.
31. Ogawa Y., et al. Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis. Clin. Cancer Res. 1998, 4:31-36.
32. O'Hanlon D., Fitzsimons H., Lynch J., Tormey S., Malone C., Given H. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur. J. Cancer 2002, 38:2252-2257.
33. Opala T., Drews K., Rzymski P., Woźniak J., Sajdak S. Evaluation of soluble intracellular adhesion molecule-1 (sICAM-1) in benign and malignant ovarian masses. Eur. J. Gynaecol. Oncol. 2003, 24:255.
34. Qing-lei W., et al. Polymorphisms of the ICAM-1 exon 6 (E469K) are associated with differentiation of colorectal cancer. J. Exp. Clin. Cancer Res. 2009, 28.
35. Ramakrishna V., et al. Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells. Int. J. Cancer 1997, 73:143-150.
36. Reilly P.L., Woska J., Jeanfavre D.D., McNally E., Rothlein R., Bormann B.J. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1 [published erratum appears in J Immunol 1996 Apr 15; 156 (8): following 3088]. J. Immunol. 1995, 155:529-532.
37. Roland C.L., Harken A.H., Sarr M.G., Barnett C.C. ICAM-1 expression determines malignant potential of cancer. Surgery 2007, 141:705-707.
38. Rosette C., et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 2005, 26:943-950.
39. Santin A.D., et al. Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int. J. Cancer 1996, 65:688-694.
40. Schröder C., et al. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer. J. Cancer Res. Clin. Oncol. 2011, 1-9.
41. Tian M.M., Sun Y., Li Z.W., Wu Y., Zhao A.L., Li J.Y. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J. Gastroenterol. 2012, 18:368-374.
42. Tung K.H., et al. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am. J. Epidemiol. 2004, 159:750-758.
43. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
44. Wang H., Kachman M.T., Schwartz D.R., Cho K.R., Lubman D.M. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers. Proteomics 2004, 4:2476-2495.
45. Wang S., Coleman E.J., Pop L.M., Brooks K.J., Vitetta E.S., Niederkorn J.Y. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. Int. J. Cancer 2006, 118:932-941.